31.10.2012 Views

ELS-tíðindi - janúar 2002 - Einkaleyfastofan

ELS-tíðindi - janúar 2002 - Einkaleyfastofan

ELS-tíðindi - janúar 2002 - Einkaleyfastofan

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

1/02<br />

Einkaleyfi<br />

Nýjar<br />

umsóknir<br />

Yfirlit skv. 8. gr. rg. nr.<br />

574/1991, með síðari<br />

breytingum, yfir<br />

umsóknir sem hafa<br />

verið lagðar inn hjá<br />

Einkaleyfastofunni í<br />

desember 2001.<br />

Birtingin felur ekki í sér<br />

að umsóknirnar verði<br />

aðgengilegar. Það gerist<br />

fyrst við birtingu undir<br />

yfirskriftinni Aðgengilegar<br />

umsóknir.<br />

(21) 6191<br />

(22) 5.12.2001<br />

(51) B65D<br />

(54) Ílát.<br />

(71) QPod Systems Limited, Unit B/218<br />

Marua Rd, Mt Wellington 1006,<br />

Auckland, Nýja-Sjálandi.<br />

(72) Arthur Frank Bollen, Ngahinapouri,<br />

Nýja Sjálandi.<br />

(74) Faktor einkaleyfaskrifstofa, ehf.,<br />

Pósthólf 678, 121 Reykjavík.<br />

(30) 8.6.99, NZ, 336144<br />

(85) 5.12.2001<br />

(86) 7.6.2000, PCT/NZ00/00092<br />

(21) 6192<br />

(22) 7.12.2001<br />

(51) C12N<br />

(54) Stýrlar úr Atlantshafslaxi.<br />

(71) GenoMar ASA, Forskningsparken,<br />

Gaustadalléen 21, N-0349 Oslo,<br />

Noregi.<br />

(72) Mohasina Syed, Fjellhamar, Noregi;<br />

Maria Lundin, Älvsjä, Svíþjóð.<br />

(74) Sigurjónsson & Thor, ehf.,<br />

Skólavörðustíg 16, 101 Reykjavík.<br />

(30) 10.6.99, NO, 19992819<br />

(85) 7.12.2001<br />

(86) 9.6.2000, PCT/NO00/00202<br />

<strong>ELS</strong> <strong>tíðindi</strong> 59<br />

(21) 6193<br />

(22) 7.12.2001<br />

(51) A61K<br />

(54) Aðferð til að tálma þyrpingu amyloið<br />

protína og til að fá mynd af<br />

útfellingum þeirra.<br />

(71) Warner-Lambert Company;<br />

Yamanouchi Pharmaceutical<br />

Company, Ltd., Tabor Road, Morris<br />

Plains, New Jersey 07950,<br />

Bandaríkjunum; 17-1, Hasune 2chome,<br />

Itabashi ku, Tokyo 174-8612,<br />

Japan.<br />

(72) Corinne Elizabeth Augelli-Szafran,<br />

Ann Arbor, Michigan, Bandaríkjunum;<br />

Mark Robert Barvian, Ann Arbor,<br />

Michigan, Bandaríkjunum;<br />

Christopher Franklin Bigge, Ann<br />

Arbor, Michigan, Bandaríkjunum;<br />

Shelly Ann Glase, Ann Arbor,<br />

Michigan, Bandaríkjunum; Shunichiro<br />

Hachiya, Tsukuba, Ibaraki, Japan;<br />

John Steven Keily, San Diego,<br />

California, Bandaríkjunum; Takenori<br />

Kimura, Tsukuba, Ibaraki, Japan;<br />

Yingjie Lai, Edison, New Jersey,<br />

Bandaríkjunum; Annette Theresa<br />

Sakkab, Northville, Michigan,<br />

Bandaríkjunum; Mark James Suto,<br />

La Jolla, California, Bandaríkjunum;<br />

Lary Craswell Walker, Ann Arbor,<br />

Michigan, Bandaríkjunum; Tomoyuki<br />

Yasunaga, Ushiku-shi, Ibaraki, Japan;<br />

Nian Zhuang, Ypsilanti, Michigan,<br />

Bandaríkjunum.<br />

(74) PATICE, Ólafur Ragnarsson, hrl.,<br />

Skeifunni 7, 108 Reykjavík.<br />

(30) 10.6.99, US, 60/138,550<br />

(85) 7.12.2001<br />

(86) 31.5.2000, PCT/US00/15071<br />

(21) 6194<br />

(22) 10.12.2001<br />

(51) A61K<br />

(54) Serínprótínasar úr fiski og notkun<br />

þeirra í lyf og snyrtivörur.<br />

(71) Jón Bragi Bjarnason, Skildinganesi<br />

29, 101 Reykjavík, Íslandi.<br />

(72) Jón Bragi Bjarnason, Reykjavík,<br />

Íslandi.<br />

(74) A&P Árnason ehf., Efstaleiti 5, 103<br />

Reykjavík.<br />

(30) 18.6.99, IS, 5086<br />

(85) 10.12.2001<br />

(86) 15.6.2000, PCT/IS00/00005<br />

(21) 6195<br />

(22) 10.12.2001<br />

(51) A61K; C12N; A61P<br />

(54) Notkun á mótefnum gegn CD20 til<br />

meðhöndlunar á þegahöfnunarveiki.<br />

(71) Consiglio Nazionale Delle<br />

Ricerche, P.le Aldo Moro 7, I-00185<br />

Roma, Ítalíu.<br />

(72) Josee Golay, Milano, Martino Introna;<br />

Milano; Alessandro Rambaldi,<br />

Bergamo; Andrea Biondi, Monza;<br />

Ítalíu.<br />

(74) Faktor einkaleyfaskrifstofa, ehf.,<br />

Pósthólf 678, 121 Reykjavík.<br />

(30) 11.6.99, IT, MI99A001299<br />

(85) 10.12.2001<br />

(86) 7.6.2000, PCT/EP00/05212<br />

(21) 6196<br />

(22) 11.12.2001<br />

(51) C07H<br />

(54) Púrín afleiður.<br />

(71) Pfizer Inc., 235 East 42nd Street,<br />

New York, New York 10017,<br />

Bandaríkjunum.<br />

(72) Simon John Mantell; Sandra Marina<br />

Monaghan; Sandwich, Kent,<br />

Bretlandi.<br />

(74) Faktor einkaleyfaskrifstofa, ehf.,<br />

Pósthólf 678, 121 Reykjavík.<br />

(30) 15.6.99, GB, 9913932.1<br />

(85) 11.12.2001<br />

(86) 13.6.2000, PCT/IB00/00789<br />

(21) 6197<br />

(22) 13.12.2001<br />

(51) A61M<br />

(54) Aðferð og búnaður til að koma<br />

lyfjablöndum á úðaform.<br />

(71) Inhale Therapeutic Systems, Inc.,<br />

150 Industrial Road, San Carlos,<br />

California 94070, Bandaríkjunum.<br />

(72) Carlos Schuler, Cupertino; Steve<br />

Paboojian, Menlo Park; Derrick J.<br />

Tuttle, San Mateo; Adrian E. Smith,<br />

Belmont; Dennis R. Rasmussen,<br />

Santa Clara; Aneesh Bakshi,<br />

Belmont; Andrew Clark, Woodside;<br />

Brian R. S. Ward, Los Altos; William<br />

W. Alston, Jr., San Jose; Kevin S.<br />

Nason, Mountain View; California,<br />

Bandaríkjunum.<br />

(74) A&P Árnason ehf., Efstaleiti 5, 103<br />

Reykjavík.<br />

(30) 30.6.99, US, 60/141,793<br />

18.4.2000, US, 60/198,060<br />

(85) 13.12.2001<br />

(86) 29.6.2000, PCT/US00/18084

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!